drugset / Trial / NCT02483455
ALC-919 For The Treatment Of Common Warts
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a single-center, randomized, double blind, vehicle-controlled phase 2 study of subjects 8 years of age and older with Common Warts (Verruca vulgaris) who desire treatment.
Timeline
- Start
- 2015-04
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALC-919 | Unknown | — | Topical |